The Department of Health is offering a grant to fund collaborative research projects focusing on identifying and characterizing patients at risk of cancer treatment-related cardiotoxicity. The grant aims to improve cardiovascular function while enhancing cancer treatment outcomes by integrating evidence-based cancer regimens with cardiovascular screening and management strategies. Research should target mitigating adverse effects of anti-cancer treatments, including chemotherapy, targeted agents, and radiation, throughout treatment and survivorship. Applications emphasizing the mitigation and management of cardiac and vascular-related adverse events are encouraged. Closing date for submissions is January 7, 2022.
Opportunity ID: 311319
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PA-19-112 |
| Funding Opportunity Title: | Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 17, 2018 |
| Last Updated Date: | Dec 17, 2018 |
| Original Closing Date for Applications: | Jan 07, 2022 |
| Current Closing Date for Applications: | Jan 07, 2022 |
| Archive Date: | Feb 12, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses City or township governments Public and State controlled institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) County governments For profit organizations other than small businesses Native American tribal governments (Federally recognized) State governments Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) encourages collaborative applications that will contribute to the identification and characterization of patients at risk of developing cancer treatment-related cardiotoxicity. The primary intent is to mitigate cardiovascular dysfunction while optimizing cancer outcomes. To accomplish this, methods that evaluate cardiovascular risk prior to treatment and integrate evidence-based cancer treatment regimens with cardiovascular screening, diagnostic, and/or management strategies are sought. Research applications should focus on mitigation/management of adverse effects associated with anti-cancer treatments including: cytotoxic chemotherapies, targeted agents, immunomodulatory therapies and radiation (that occur during cancer treatment and/or long-term survivorship) as defined by cardiac and/or vascular specific common terminology criteria for adverse events (CTCAE). |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-19-112.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00247003 | Jan 05, 2019 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00259067 | Jan 05, 2019 | Jan 24, 2022 | View | |
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00269666 | Oct 28, 2021 | Jan 07, 2022 | View |
Package 1
Mandatory forms
311319 RR_SF424_2_0-2.0.pdf
311319 PHS398_CoverPageSupplement_4_0-4.0.pdf
311319 RR_OtherProjectInfo_1_4-1.4.pdf
311319 PerformanceSite_2_0-2.0.pdf
311319 RR_KeyPersonExpanded_2_0-2.0.pdf
311319 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
311319 RR_Budget_1_4-1.4.pdf
311319 RR_SubawardBudget30_1_4-1.4.pdf
311319 PHS398_ModularBudget_1_2-1.2.pdf
311319 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
311319 RR_SF424_2_0-2.0.pdf
311319 PHS398_CoverPageSupplement_5_0-5.0.pdf
311319 RR_OtherProjectInfo_1_4-1.4.pdf
311319 PerformanceSite_2_0-2.0.pdf
311319 RR_KeyPersonExpanded_2_0-2.0.pdf
311319 PHS398_ResearchPlan_4_0-4.0.pdf
311319 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
311319 RR_Budget_1_4-1.4.pdf
311319 RR_SubawardBudget30_1_4-1.4.pdf
311319 PHS398_ModularBudget_1_2-1.2.pdf
311319 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
311319 RR_SF424_5_0-5.0.pdf
311319 PHS398_CoverPageSupplement_5_0-5.0.pdf
311319 RR_OtherProjectInfo_1_4-1.4.pdf
311319 PerformanceSite_4_0-4.0.pdf
311319 RR_KeyPersonExpanded_4_0-4.0.pdf
311319 PHS398_ResearchPlan_4_0-4.0.pdf
311319 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
311319 RR_Budget_3_0-3.0.pdf
311319 RR_SubawardBudget30_3_0-3.0.pdf
311319 PHS398_ModularBudget_1_2-1.2.pdf
311319 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
